SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-074237
Filing Date
2018-03-08
Accepted
2018-03-08 08:14:56
Documents
3
Period of Report
2018-03-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d535640d8k.htm 8-K 17662
2 EX-99.1 d535640dex991.htm EX-99.1 81135
3 GRAPHIC g535640g0308052047855.jpg GRAPHIC 3237
  Complete submission text file 0001193125-18-074237.txt   104725
Mailing Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110
Business Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110 617-639-1500
JUNIPER PHARMACEUTICALS INC (Filer) CIK: 0000821995 (see all company filings)

IRS No.: 592758596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10352 | Film No.: 18675068
SIC: 2834 Pharmaceutical Preparations